Furthermore, in order to differentiate PCV patients among exudative AMD patients, we checked, by hand, the 130 research articles passing the filtering criteria, and we selected only those studying the genetic variants affecting the response to anti-VEGF drugs in PCV patients exclusively (Figure 1). The gene discussed is VEGFA; the disease is age-related macular degeneration.